Resting Metabolic Rate, Fat Distribution, Endocrine and Metabolic Features in Polycystic Ovary Syndrome
1 other identifier
observational
160
0 countries
N/A
Brief Summary
In a longitudinal, prospective and observational study, patients with PCOS and controls wore the SenseWear Armband for 2 days. Resting metabolic rati (kcal/die), total energy expenditure (MET, kcal) were evaluated. Ultrasonographic pelvic examinations, hirsutism score, anthropometric and menstrual pattern evaluation, hormonal profile assays, oral glucose tolerance test (OGTT) and lipid profile were performed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2013
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2017
CompletedFirst Submitted
Initial submission to the registry
April 24, 2017
CompletedFirst Posted
Study publicly available on registry
April 28, 2017
CompletedApril 28, 2017
April 1, 2017
3.9 years
April 24, 2017
April 24, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
differences in resting metabolic rate
2 days
Secondary Outcomes (1)
differences in body fat distribution
1 day
Study Arms (2)
PCOS
controls
Interventions
Participants wore the SWA on their right arm
DEXA was used to estimate abdominal visceral adipose tissue and subcutaneous adipose tissue
Eligibility Criteria
group 1: women with PCOS diagnosed according with the Rotterdam Consensus Conference criteria group 2: healty women
You may qualify if:
- PCOS diagnosed according with the Rotterdam Consensus Conference criteria
You may not qualify if:
- presence of a late-onset adrenal enzyme defect
- Significant liver or renal impairment
- pregnancy and nursing
- neoplasm
- cardiovascular disease
- other hormonal dysfunctions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Romualdi D, Versace V, Tagliaferri V, De Cicco S, Immediata V, Apa R, Guido M, Lanzone A. The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study. J Endocrinol Invest. 2019 Sep;42(9):1089-1097. doi: 10.1007/s40618-019-01029-2. Epub 2019 Mar 7.
PMID: 30847861DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
April 24, 2017
First Posted
April 28, 2017
Study Start
January 1, 2013
Primary Completion
December 1, 2016
Study Completion
March 1, 2017
Last Updated
April 28, 2017
Record last verified: 2017-04